Prof Jonathan Benger: key facts
- Kind of voice
- Academic
- Role
- chief medical officer and interim director of the Centre for Guidelines at NICE
- Quoted on
- Women's health & gynaecology
- Press citations held
- 5
- Most recently quoted
- 30 Sept 2026
“the updated guidance now makes it clear that HRT is the 'recommended first line treatment for vasomotor symptoms'”
What Prof Jonathan Benger has said
“We are not suggesting that CBT is an alternative to HRT. It's not an either/or, and we have worked through the guidelines extensively to really clarify this point. We are very keen to emphasise that HRT is our recommended first-line therapy for vasomotor symptoms [night sweats and hot flushes] and for [other] symptoms of menopause.”
Chief Medical Officer and Interim Director of the Centre for Guidelines at NICE · Women's health & gynaecology · 30 Sept 2026 · HRT should be the first line of treatment for menopause symptoms, experts say ↗
“Women need to feel confident that they will be offered advice and options that meet their needs, and that they will be supported to make the choices that are right for them.”
chief medical officer at NICE · Women's health & gynaecology · 30 Sept 2026 · NICE stresses HRT as first-line menopause treatment ↗
“NICE is delighted to collaborate with the Monash Centre for Health Research and Implementation. NICE strives to produce guidance which is not only high quality and meets user needs but is also timely. Adapting the highly regarded International Guideline on PCOS was the best way for NICE to achieve all three objectives in this case.”
Chief Medical Officer at NICE · Women's health & gynaecology · 30 Sept 2026 · UK National Institute for Health and Care Excellence (NICE) to adapt Monash-led International PCOS Guideline for UK health professionals ↗
“We are not suggesting that CBT is an alternative to HRT. It's not an either/or, and we have worked through the guidelines extensively to really clarify this point. We are very keen to emphasise that HRT is our recommended first-line therapy for vasomotor symptoms [night sweats and hot flushes] and for [other] symptoms of menopause.”
Chief Medical Officer and interim director of the centre for guidelines at Nice · Women's health & gynaecology · 29 Sept 2026 · HRT should be offered as first-line treatment for menopause, says Nice ↗
Where Prof Jonathan Benger has been quoted
- New NICE guidance clarifies HRT as ‘first line treatment’ for menopause symptomspulsetoday.co.uk · 30 Sept 2026
- HRT should be the first line of treatment for menopause symptoms, experts saywomenshealthmag.com · 30 Sept 2026
- NICE stresses HRT as first-line menopause treatmentbbc.com · 30 Sept 2026
- UK National Institute for Health and Care Excellence (NICE) to adapt Monash-led International PCOS Guideline for UK health professionalsmonash.edu · 30 Sept 2026
- HRT should be offered as first-line treatment for menopause, says Nicetheguardian.com · 29 Sept 2026
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 30 Sept 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.